C Difficile

8500 bookmarks
Custom sorting
US Human Microbiome Market Size, Share, Industry, Forecast to 2029
US Human Microbiome Market Size, Share, Industry, Forecast to 2029
The US Human Microbiome Market 2023 Report makes available the current and forthcoming technical and financial details of the industry It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies It ...
·news.google.com·
US Human Microbiome Market Size, Share, Industry, Forecast to 2029
Total Abdominal Colectomy Versus Diverting Loop Ileostomy and Antegrade Colonic Lavage for Fulminant Clostridioides Colitis: Analysis of the National Inpatient Sample 2016-2019 - PubMed
Total Abdominal Colectomy Versus Diverting Loop Ileostomy and Antegrade Colonic Lavage for Fulminant Clostridioides Colitis: Analysis of the National Inpatient Sample 2016-2019 - PubMed
There are minimal differences between TAC and DLI with antegrade colonic lavage for fulminant CDI in terms of postoperative morbidity and mortality. Healthcare resource utilization, however, is significantly improved when patients undergo TAC as evidenced by clinically important decreases in total a …
·pubmed.ncbi.nlm.nih.gov·
Total Abdominal Colectomy Versus Diverting Loop Ileostomy and Antegrade Colonic Lavage for Fulminant Clostridioides Colitis: Analysis of the National Inpatient Sample 2016-2019 - PubMed
Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019-20201 - PubMed
Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019-20201 - PubMed
Although Clostridioides difficile infection (CDI) incidence is high in the United States, standard-of-care (SOC) stool collection and testing practices might result in incidence overestimation or underestimation. We conducted diarrhea surveillance among inpatients 50 years of age in Louisville, …
·pubmed.ncbi.nlm.nih.gov·
Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019-20201 - PubMed
Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile- Specific DNA Adenine Methyltransferase - PubMed
Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile- Specific DNA Adenine Methyltransferase - PubMed
S-Adenosyl-l-methionine (SAM) analogs are adaptable tools for studying and therapeutically inhibiting SAM-dependent methyltransferases (MTases). Some MTases play significant roles in host-pathogen interactions, one of which is Clostridioides difficile-specific DNA adenine MTase (CamA). …
·pubmed.ncbi.nlm.nih.gov·
Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile- Specific DNA Adenine Methyltransferase - PubMed
Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020 - PubMed
Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020 - PubMed
Recurrent Clostridioides difficile infection (RCDI) causes an increased burden on the healthcare system. We calculated RCDI incidence and identified factors associated with RCDI cases in New Haven County, Connecticut, USA, during 2015-2020 by using data from population-based laboratory surveillance. …
·pubmed.ncbi.nlm.nih.gov·
Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020 - PubMed
Validating agent-based simulation model of hospital-associated Clostridioides difficile infection using primary hospital data - PubMed
Validating agent-based simulation model of hospital-associated Clostridioides difficile infection using primary hospital data - PubMed
As agent-based models (ABMs) are increasingly used for modeling infectious diseases, model validation is becoming more crucial. In this study, we present an alternate approach to validating hospital ABMs that focuses on replicating hospital-specific conditions and proposes a new metric for validatin …
·pubmed.ncbi.nlm.nih.gov·
Validating agent-based simulation model of hospital-associated Clostridioides difficile infection using primary hospital data - PubMed
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus - PubMed
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus - PubMed
SLE patients have disruptions in multiple microbiomes, with the gut microbiota (bacteria, viruses, and fungi) and their metabolites being the most thoroughly researched. This dysbiosis can promote SLE progression through mechanisms such as the leaky gut, molecular mimicry, and epigenetic regulation. …
·pubmed.ncbi.nlm.nih.gov·
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus - PubMed
Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control - PubMed
Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control - PubMed
Alzheimer's disease (AD) is the most common type of dementia in the elderly and causes neurodegeneration, leading to memory loss, behavioral disorder, and psychiatric impairment. One potential mechanism contributing to the pathogenesis of AD may be the imbalance in gut microbiota, local and systemic …
·pubmed.ncbi.nlm.nih.gov·
Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control - PubMed
Probiotics for primary prevention of Clostridioides difficile infection: revisiting the evidence - PubMed
Probiotics for primary prevention of Clostridioides difficile infection: revisiting the evidence - PubMed
Prophylactic probiotics have been shown to be effective in preventing Clostridioides difficile infection (CDI), according to multiple meta-analyses. However, different medical societies have varying recommendations on their use for preventing CDI. In this commentary, we discuss current eviden …
·pubmed.ncbi.nlm.nih.gov·
Probiotics for primary prevention of Clostridioides difficile infection: revisiting the evidence - PubMed
Ferring to Present Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, at DDW 2023
Ferring to Present Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, at DDW 2023
Ferring Pharmaceuticals today announced it will present analyses of data for REBYOTA™ (fecal microbiota, live – jslm) at Digestive Disease Week® (DDW 2023). The congress will take place May 6-9, 2023, in
·news.google.com·
Ferring to Present Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, at DDW 2023
Stool Biobank Project by the International Society of Microbiota: Call for Collaboration
Stool Biobank Project by the International Society of Microbiota: Call for Collaboration
The International Society of Microbiota is calling for a new project on Stool & Microbiota Bank Services. The International Society of Microbiota (ISM) is currently looking for stool storage facility or biobank service for screened and processed stool sample in academics, research institutes, hospitals or industries.
·news.google.com·
Stool Biobank Project by the International Society of Microbiota: Call for Collaboration
Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control - PubMed
Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control - PubMed
Alzheimer's disease (AD) is the most common type of dementia in the elderly and causes neurodegeneration, leading to memory loss, behavioral disorder, and psychiatric impairment. One potential mechanism contributing to the pathogenesis of AD may be the imbalance in gut microbiota, local and systemic …
·pubmed.ncbi.nlm.nih.gov·
Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control - PubMed
Dry alginate beads for fecal microbiota transplantation: from model strains to fecal samples - PubMed
Dry alginate beads for fecal microbiota transplantation: from model strains to fecal samples - PubMed
Clostridioides difficile infection (CDI) is a critical nosocomial infection with more than 124,000 cases per year in Europe and a mortality rate of 15-17%. The standard of care (SoC) is antibiotic treatment. Unfortunately, the relapse rate is high (∼35%) and SoC is significantly less effective again …
·pubmed.ncbi.nlm.nih.gov·
Dry alginate beads for fecal microbiota transplantation: from model strains to fecal samples - PubMed
World Gastroenterology Organisation (WGO)
World Gastroenterology Organisation (WGO)
The World Gastroenterology Organisation (WGO) is a federation of over 100 Member Societies and four Regional Associations of gastroenterology representing over 50,000 individual members worldwide.
·worldgastroenterology.org·
World Gastroenterology Organisation (WGO)
Practical observations on the use of fluorescent reporter systems in Clostridioides difficile - PubMed
Practical observations on the use of fluorescent reporter systems in Clostridioides difficile - PubMed
Fluorescence microscopy is a valuable tool to study a broad variety of bacterial cell components and dynamics thereof. For Clostridioides difficile, the fluorescent proteins CFPsupopt/sup, mCherrysupOpt/sup and phiLOV2.1, and the self-labelling tags SNAPsupCd/sup and HaloTag, hereafter c …
·pubmed.ncbi.nlm.nih.gov·
Practical observations on the use of fluorescent reporter systems in Clostridioides difficile - PubMed
Fecal microbiota transplants: 10 questions, answered
Fecal microbiota transplants: 10 questions, answered
What should cancer patients know about fecal microbiome transplants? We asked gastroenterologist and researcher Yinghong “Mimi” Wang, M.D., Ph.D.
·mdanderson.org·
Fecal microbiota transplants: 10 questions, answered
Fecal microbiota transplants: 10 questions, answered
Fecal microbiota transplants: 10 questions, answered
What should cancer patients know about fecal microbiome transplants? We asked gastroenterologist and researcher Yinghong “Mimi” Wang, M.D., Ph.D.
·news.google.com·
Fecal microbiota transplants: 10 questions, answered
MTIG on Twitter
MTIG on Twitter
On April 24th, @PeggyFund will host the 2023 National C. diff Advocacy Summit. During the event #CDiff patients, caregivers and healthcare industry members will discuss their experiences and strategies to fight this potentially life-threatening disease. https://t.co/WMnMENqxvp— MTIG (@MTIG_News) April 19, 2023
·twitter.com·
MTIG on Twitter
Synthesis of Muramyl-δ-Lactam in Spore Peptidoglycan of Clostridioides difficile - PubMed
Synthesis of Muramyl-δ-Lactam in Spore Peptidoglycan of Clostridioides difficile - PubMed
Clostridioides difficile is a spore-forming human pathogen responsible for significant morbidity and mortality. Infections by this pathogen ensue dysbiosis of the intestinal tract, which lead to germination of the spores. The process of spore formation requires a transition for the cell-wall peptido …
·pubmed.ncbi.nlm.nih.gov·
Synthesis of Muramyl-δ-Lactam in Spore Peptidoglycan of Clostridioides difficile - PubMed
Acurx Announces Ibezapolstat Scientific Poster and Update on its Pol IIIC Pipeline Presented at ECCMID 2023 Scientific Conference | MarketScreener
Acurx Announces Ibezapolstat Scientific Poster and Update on its Pol IIIC Pipeline Presented at ECCMID 2023 Scientific Conference | MarketScreener
A scientific poster highlighting a novel pharmacologic property of oral ibezapolstat for C. difficile Infection likely related to its unique mechanism of action was presented at ECCMID 2023An update... | April 19, 2023
·news.google.com·
Acurx Announces Ibezapolstat Scientific Poster and Update on its Pol IIIC Pipeline Presented at ECCMID 2023 Scientific Conference | MarketScreener